Erythropoietin treatment and osteoporotic fracture risk in hemodialysis patients: A nationwide population-based study
{{output}}
Objectives: Concerns about erythropoietin (EPO) therapy for anemia in patients with end-stage renal disease (ESRD) contributing to potential bone loss and increased fracture risks are growing. This study investigated the impact o... ...
